we enrolled 115 consecutive Japanese patients who presented to our hospital with acute HF, and were diagnosed and treated by a cardiologist, based on physical examination, chest radiograph, laboratory tests, and echocardiography, and according to the American Heart Association guidelines. The patients received standard HF therapy, including vasodilators, diuretics and dopamine, or dobutamine. Patients presenting with acute myocardial infarction; shock, defined as hypotension requiring continuous infusions of norepinephrine; overt infection; a history of dialysis; or need for ventricular assist device or mechanical ventilation were excluded from this study. To preserve the integrity of the data and expedite the handling and storage of samples collected, we excluded patients ad-The online-only Data Supplement is available at http://circheartfailure.ahajournals.org/lookup/suppl/Background-Urine albumin excretion is an important predictor of adverse cardiovascular events in various populations. Its correlation in patients with acute heart failure has not been described. Methods and Results-This prospective, observational study included 115 patients presenting with acute heart failure. The urine albumin/creatinine ratio (UACR) was measured from spot urine samples collected on days 1 and 7 of hospitalization. Median UACR decreased from 83 to 22 mg/gCr on days 1 and 7, respectively (P<0.0001). The proportion of patients with normoalbuminuria (UACR <30 mg/gCr) increased from 31% on day 1 to 60% on day 7, whereas the proportion with microalbuminuria (UACR between 30 and 299 mg/gCr) and macroalbuminuria (UACR ≥300 mg/gCr) decreased, respectively, from 42% and 27% on day 1 to 30% and 10% on day 7 (P<0.0001). These changes in UACR were correlated with changes in serum bilirubin and N-terminal pro b-type natriuretic peptide concentrations (correlation coefficients 1.087 and 0.384, respectively; 95% confidence interval, 0.394-1.781 and 0.087-0.680, respectively; and P=0.003 and 0.013, respectively), although they were not correlated with change in estimated glomerular filtration rate.
U rinary albumin excretion (UAE) is an independent predictor of adverse cardiovascular events or worsening renal function in the general population, 1 in hypertensive or diabetic patients, 2, 3 and in patients presenting with coronary artery disease. 4 Large, recently published studies have reported a high prevalence of albuminuria in patients with chronic heart failure (HF) and showed that, in these patients, UAE was often increased in the absence of diabetes mellitus or hypertension and independently predicted a risk of adverse cardiovascular events. 5, 6 Several mechanisms were considered to explain UAE, including activation of neurohumoral factors, 7,8 vascular dysfunction, 9 systemic inflammation, 10 altered renal hemodynamics, 11 and glomerular and tubular dysfunction. 12 In addition, some of these abnormal characteristics are exacerbated in patients presenting with acute HF and are alleviated by the management of cardiac decompensation. However, the frequency and dynamics of UAE in patients presenting with acute HF have not been described. Therefore, we planned this prospective observational study of the baseline characteristics associated with various severity levels of UAE, expressed as the urine albumin/creatinine ratio (UACR) and correlates of changes (∆) in UACR during treatment of acute HF.
Study Measurements
At admission, the patients underwent a review of their medical history and drug therapy. An ischemic pathogenesis was defined as a history of revascularization or manifestations of myocardial ischemia. Atrial fibrillation was diagnosed based on the rhythm recorded at admission. Diabetes mellitus was defined as a fasting serum glucose ≥126 mg/ dL, nonfasting serum glucose >200 mg/dL, or use of an antidiabetic medication. Body height and weight, systemic blood pressure, and heart rate were recorded throughout the course of treatment. Body mass index (BMI) was calculated as the body weight, in kg, divided by the square of the height, in meter. Left-ventricular ejection fraction was measured by ventriculography or echocardiography, calculated by modified 2-dimensional Simpson method or Teichholz formula.
Blood and spot urine samples were collected ≤6 hours after admission of the patient to the hospital. The day 7 samples were collected between day 6 and day 8 of hospitalization, depending on which day of the week the patient was admitted, to guarantee proper storage of the samples, as mentioned earlier. Blood measurements included serum hemoglobin, albumin, bilirubin, blood urea nitrogen, creatinine, and N-terminal pro b-type natriuretic peptide (NT-pro BNP). Because the equation used to estimate the glomerular filtration rate in Western countries might not be applicable to Asian patients, we used recently published equations for Japanese men (194×serum creatinine −1.094 ×age −0.287 ) and women (194×serum creatinine −1.094 ×age −0.287 ×0.739). 13 NT-proBNP was measured, using an Elecsys 2010 system (Roche Diagnostics, Tokyo, Japan). The urine samples were refrigerated and transferred to a central laboratory. The urinary albumin and creatinine concentrations were measured, using the Nittobo N assay TIA micro Alb system (Nittobo Medical, Tokyo, Japan). All study procedures were in compliance with the principles outlined in the Declaration of Helsinki and the institutional guidelines of Hyogo Prefectural Amagasaki Hospital. The authors had full access to and take responsibility for the integrity of the data.
Statistical Analysis
Normally distributed continuous variables are presented as means±SD. Because of the positively skewed distributions of BMI, serum bilirubin, creatinine, NT-pro BNP, and UACR, these variables were log transformed for analysis, and are presented as medians and 25th and 75th percentiles. As a categorical variable, according to the UACR, the patients were classified as <30 mg/gCr, normoalbuminuria; 30 to 299 mg/gCr, microalbuminuria; and ≥300 mg/gCr, macroalbuminuria.
The differences in mean log UACR between day 1 and day 7 were examined by paired t test in all patients and subgroups divided by concomitant renal impairment ( Figure 1 ). To reach an 80% power at an alpha level of 0.05, the sample SD (1.83) and sample mean (1.17) ∆UACR required a sample size of 27. Because the sample size available was sufficient, the calculated power of this analysis was ≈1.00. Increasing the SD to 2.5 or 3.0 preserved the detection power at 0.999 or 0.986, respectively, with the 115 patients included in the analysis. The power analyses performed in the renal function subgroup yielded similar results. The effect of a decreased renal function on a decrease in UACR was also tested by multivariate ANOVA. The changes in UAE category were examined by extended McNemar test.
Differences in baseline clinical and laboratory characteristics among patients with normo-, micro-, and macroalbuminuria on days 1 and 7 were tested by Fisher exact test for categorical variables and Kruskal-Wallis test for continuous variables.
Bivariate and multivariable analyses were performed to identify the determinants of baseline UACR. Factors with a probability value of ≤0.10 by single variable linear regression analyses were included in a multivariable linear regression analyses together with age and sex. Baseline BMI was unavailable in 6 patients who could not be weighed at admission. Therefore, these 6 patients were excluded from the analyses of the relationships between baseline characteristics and baseline UACR.
The relationships between ∆UACR during the treatment period and baseline characteristics or ∆ in other variables were also tested. ∆ in normally distributed variables were defined as the differences between baseline and subsequent measurements, and ∆ in non-normally distributed variables were defined as the differences between baseline and subsequent log-transformed measurements. Simple linear regression analyses were performed to examine the relationship between baseline characteristics and ∆ in other variables and ∆UACR. Thereafter, a multivariable linear regression analysis was performed, which included age, sex, and the factors with a probability value of ≤0.10 in the bivariate analyses.
Most statistical analyses were performed with the JMP software, version 9.0 (SAS Corporation, Cary, NC). Fisher exact and extended McNemar tests were performed with R version 2.14.0 (Vienna, Austria, URL: http://www.r-project.org).
Results

Prevalence of UAE and Baseline Correlates
At admission to the hospital, 31 patients (27%) presented with macroalbuminuria, 48 patients (42%) with microalbuminuria, and 36 patients (31%) with normoalbuminuria. The baseline characteristics of each subgroup are shown in Table 1 . A vasodilator was administered to 94% of patients, including isosorbidedinitrate in 45%, carperitide in 54%, and both vasodilators in 5% of patients. Dopamine or dobutamine was administered to 28% of patients. The mean log UACR decreased with the alleviation of HF, regardless of the presence or absence of changes in renal function ( Figure 1 ). The proportion of patients with micro-and macroalbuminuria also decreased significantly. On day 7, 69 patients (60%) were free from albuminuria, 12 patients (10%) were macroalbuminuric, and 34 patients (30%) were microalbuminuric ( Figure 2 ; Table I in the online-only Data Supplement).
Association With Baseline UAE Ratio
By bivariate analysis, the baseline UACR was positively correlated with BMI, blood pressure, serum blood urea nitrogen, creatinine, and NT-pro BNP; and negatively correlated with serum albumin and estimated glomerular filtration rate. By multivariable analysis, BMI, blood pressure, NT-pro BNP, and estimated glomerular filtration rate were independently correlated with UACR. A 1 mL per 1.73 m 2 increase in estimated glomerular filtration rate was associated with 0.019 U decreases Log-transformed urine albumin/creatinine ratio (UACR) decreased significantly between day 1 and day 7 in all subgroups (*P<0.0001 vs UACR on day 1). Although log-transformed UACR at baseline and on day 7 was correlated with baseline renal function ( †P<0.0001 vs the group with eGFR <45 mL/min per 1.73 m 2 ), it was not correlated with the amount of change in UACR (tested by multivariable ANOVA). eGFR indicates estimated glomerular filtration rate.
in log UACR. A 1 mm Hg increase in mean blood pressure, and 1 U increase in log BMI and NT-pro BNP were associated with 0.031, 2.41, and 0.408 U increases in log UACR, respectively ( Table II in 
Association With Changes in UAE Ratio
By bivariate analyses, decreases in heart rate, blood pressure, serum bilirubin, and NT-pro BNP were correlated with a decrease in UACR. Treatment with isosorbide dinitrate or human atrial natriuretic peptide, with or without concomitant administration of an inotrope had no effect on ∆UACR ( Table 2) . By multivariable analysis, decreases in serum bilirubin and NT-pro BNP concentrations were correlated with a decrease in UACR. A single unit decrease in log bilirubin and log NT-pro BNP concentrations were associated with a 1.087 and 0.384 U decrease in log UACR, respectively ( Table 2 ).
Discussion
Nearly 70% of our patients presenting with acute HF had abnormal UAE at admission to the hospital, a proportion that decreased to 40% after 7 days of treatment. To the best of our knowledge, this is the first report of the prevalence and correlates of UAE in patients presenting with acute HF. On day 7, the prevalence of micro-and macroalbuminuria in our study (30% and 10%, respectively) was similar to those observed in the large Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity 5 (30% and 11%, respectively) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico 6 (20% and 6%, respectively) trials.
Intrinsic kidney disorders, such as diabetic nephropathy, 14 endothelial dysfunction, 9, 15 and overexpression of neurohumoral factors 7, 8, 11, 16 are generally held as responsible for the excessive excretion of urinary albumin and prognostic consequences in HF. [17] [18] [19] [20] [21] [22] [23] An increased excretion of urinary albumin in patients presenting with chronic HF and a close correlation with prognosis had already been reported. 5, 6 In this study, at the time of hospitalization for acute cardiac decompensation, the excretion of urine albumin was greatly increased in a high proportion of patients. One might hypothesize that UAE is a surrogate marker and a reliable prognostic factor, and that its exacerbation signals the decompensation of HF and need for hospitalization. Impairment of renal function is a known predictor of outcome in HF. 17 In this study, baseline renal function was closely correlated with UAE. Chronic kidney disease causes disruptions in the size-and charge-selective glomerular barrier and increases the excretion of urinary albumin. 24 Diabetic nephropathy is the leading cause of chronic kidney disease in recent years and is more likely to be associated with proteinuria than any other renal disease. Diabetes mellitus was an important cause of increased UAE in 2 large earlier studies of patients presenting with chronic HF. 5, 6 In our study, however, no correlation was found between diabetes mellitus and UAE. We hypothesize that cachexia explains this inconsistency. The mean BMI of our patients (23 kg/m 2 ) was considerably lower than that in CHARM (30 kg/m 2 ) and GISSI-HF (27 kg/m 2 ). The progression of HF is complicated by undernutrition, 25 which might lower the concentration of hemoglobin A1c, or prompt the discontinuation of antidiabetic medications, or both. Because our diagnosis of diabetes mellitus was based on the concentrations of hemoglobin A1c, or a history of use of antidiabetic medications or diabetic consultation at admission, it might explain the absence of relationship between UACR and glycemic indices in this study.
As stated earlier, organic renal disease is a major cause of UAE. However, in this study, baseline renal function was also a major determinant of the absolute amount of UAE measured on days 1 and 7, although it was unrelated to its decrease during the treatment period. A subgroup of patients presented with overt albuminuria and mild kidney dysfunction at admission, and a decrease in UAE after treatment of decompensated HF, suggesting that the latter was the cause of functional albuminuria. Activation of the renin-angiotensin-aldosterone and sympathetic nervous systems is an important functional change associated with exacerbation of HF. 26 In large, recent clinical trials, the suppression of these factors improved the outcomes of patients with HF. [19] [20] [21] [22] [23] Excessive activation of the renin-angiotensin-aldosterone system causes glomerular hypertension and proteinuria, 7, 11 whereas its inhibition has a major impact on the severity of proteinuria. Excessive activation of the sympathetic nervous system also causes proteinuria, and carvedilol lowers the UACR in hypertensive patients. 8, 16 In addition, the hypothesis that a transient activation of neurohumoral factors might cause albuminuria was partially supported by the results of a study of patients who presented with acute coronary syndrome, in whom UAE was markedly increased at admission to the hospital. 27 However, after in-hospital management of the acute phase of the syndrome, UAE decreased significantly. The increased UAE at admission to the hospital, in this study, might have been a manifestation of excessive activation of these systems. However, inhibitors of the renin-angiotensin-aldosterone system or β-adrenergic blockers prescribed before admission of our patients to the hospital had no significant effect on the degree of proteinuria.
In a previous study, high concentrations of NT-pro BNP were correlated with high UAE in patients with chronic HF, 28 although whether a decrease in NT-pro BNP by treatment of HF lowers UAE was not examined. In our study, changes in UAE were positively correlated with changes in serum NT-pro BNP concentration, a reliable diagnostic indicator of disease severity and prognosis. This suggests a relationship between UACR and hemodynamic failure itself. One might hypothesize that the upstream circulatory congestion reflected by high-serum concentrations of NT-pro BNP 29 is the cause of elevated UAE. In experimental models, renal vein constriction increased the renal vein pressure and caused glomerular capillary hypertension, hyperfiltration, and overt proteinuria. 11, 30 These effects were observed with modest increases in renal vein pressure, similar to those attained during decompensated HF. 31 In support of this hypothesis, a high central venous pressure has been linked to a decrease in renal function in humans. 32 We observed an independent correlation between a decrease in the serum concentration of bilirubin and a decrease in UAE, which supports the hypothesis of a common underlying mechanism of bilirubinemia and albuminuria. Liver dysfunction, represented by bilirubinemia, is a common and strong prognostic indicator in patients suffering from HF. 33 In our study, ∆bilirubin was associated with ∆UACR, independently from ∆NT-pro BNP, which is a reliable biomarker of circulatory congestion. 29 This observation suggests that a common mechanism, other than congestion, contributes to bilirubinemia and albuminuria. In an experimental model, Watkins et al 34 found that, by decreasing the renal blood flow, a low-cardiac output stimulated the secretion of renin from the macula densa and induced proteinuria. In humans, Shinagawa et al 35 observed that bilirubinemia complicating low-tissue perfusion predicts the need for catecholamines in the course of treatment of HF. These studies might explain the relationship between the changes in albuminuria and bilirubinemia observed in this study.
Limitations of the Study
Our study is limited by a small sample size and by having been conducted at a single medical center. Our findings need to be confirmed in a larger, properly designed study. Because we did not systematically record the baseline physical examinations, we could not examine the relationship between clinical presentation of acute HF and UAE based on physical findings. For simplicity, and as was the case in earlier studies, 5.6 we used a single spot urine sample to ascertain the presence of UAE, which was perhaps insufficient, as it might fluctuate. However, corrected UAE by measurement of urinary creatinine is an accurate estimate of the daily protein excretion. 36 
Conclusion
We found an increase in UAE in patients presenting with acute HF, often resolved with treatment of cardiac decompensation. The resolution of UAE was independent of changes in indices of renal function, and was paralleled by decreases in serum bilirubin and NT-pro BNP.
Because of the rapidly increasing prevalence of heart failure in the general population, a clear understanding of its pathophysiology and of the potential delivery of new, targeted treatments has become a priority. Several diagnostic and prognostic biomarkers have been evaluated in the pursuit of these goals. The excretion of urinary albumin, observed in patients with chronic heart failure, is an independent predictor of adverse cardiovascular events. However, its prevalence and time course of elevation in patients presenting with acute heart failure have not been described. In this study, the median urine albumin/ creatinine ratio at admission to the hospital was 83 mg/gCr, and 69% of patients presented with albuminuria. With the alleviation of heart failure signs and symptoms, the median urine albumin/creatinine ratio decreased to 22 mg/gCr, and the rate of abnormal urinary albumin excretion decreased to 40% on day 7. This latter decrease was associated with a decrease in the serum concentrations of N-terminal B-type natriuretic peptide and bilirubin, regardless of baseline renal function. These observations that suggest that urinary albumin excretion reflects the early evolution of acute cardiac decompensation warrant further studies of its pathophysiological, clinical, and prognostic significance in a larger patient population.
